CP-724714 | HER2 inhibitor - Cellagen Technology

Loading... Please wait...

New Products

Biologix SBS Format Cryogenic Vials-1mL, 2mL, 5mL, 48-Well, Racked, External Thread, 10 Sets/Pack, 2 Packs/Case

$253.89

Choose Options
Cryogenic Vials with Side Bardcode-2.0 ml External Thread

$67.49

Choose Options
Biologix Beakers-50/100/250/400/800/1000ml, Case of 100

$22.99

Choose Options
CryoKING Liquid Nitrogen Tank - Laboratory Series 31.5 L/35.5 L, Including 6 Square Racks(4 layers) with 5*5 Cryogenic Boxes

$856.49

Choose Options
CryoKING Liquid Nitrogen Tank Portable Dewar Series 2L/3L/6L/10L

$228.19

Choose Options

Our Newsletter

CP-724714 | HER2 inhibitor

Price:

$119.00

Catalog #:

C2772-5

* Package Size:

5 mg (10 mM solution in DMSO)
5 mg (powder)
25 mg (powder)
100 mg (powder)

Quantity:

Product Description

CP-724714 is a quinazoline-based, orally-available, ATP-competitive inhibitor of erbB2 at an IC50 of 10 nM, with exquisite selectivity over EGFR kinase (6.4 uM) and >1000-fold selectivity over IR, IGFR, PDGFRb, VEGFR2, Abl, Src, cMet, JNK, CDK2, and CDK5. [1] CP-724714 is a potent inhibitor of erbB2 autophosphorylation (EC50 = 1 ug/mL) and induces G1 cell cycle arrest with concomitant reduction in S-phase cells. [1]

CP-724714 exhibits linear single-dose and multiple-dose pharmacokinetics. [2], but was discontinued from clinical development due to unexpected hepatotoxicity. [3]

Technical information:

Chemical Formula:		C₂₇H₂₇N₅O₃
CAS #:		383432-38-0
Molecular Weight:		469.53
Purity:		> 99%
Appearance:		White
Chemical Name:		(E)-2-methoxy-N-(3-(4-(3-methyl-4-(6-methylpyridin-3-yloxy)phenylamino)quinazolin-6-yl)allyl)acetamide
Solubility:		Up to 100 mM in DMSO
Synonyms:		CP-724714, CP724714, 383432-38-0

Shipping Condition: The product is shipped in a glass vial at ambient temperature.
Storage condition: For longer shelf life, store solid powder at 4^oC desiccated, or store DMSO solution at -20^oC.

Reference:

1.	Jani et al., Discovery and Pharmacologic Characterization of CP-724714, a Selective ErbB2 Tyrosine Kinase Inhibitor. Cancer Res. 2007, 67, 9887-9893. Pubmed ID: 17942920
2.	Guo et al., Pharmacokinetics of a HER2 tyrosine kinase inhibitor CP-724,714 in patients with advanced malignant HER2 positive solid tumors: correlations with clinical characteristics and safety. Cancer Chemother. Pharmacol., 2008, 62, 97-109. Pubmed ID: 17805538
3.	Feng et al., Role of Hepatic Transporters in the Disposition and Hepatotoxicity of a HER2 Tyrosine Kinase Inhibitor CP-724,714. Toxicol. Sci. 2009, 108(2), 492-500.

Other Information:

Product Specification (pdf)
MSDS (pdf)
Certificate of Analysis is available upon request.